lauric acid + omeprazole + N-acetyl cysteine

This is a **combination drug** containing lauric acid, omeprazole, and N-acetyl cysteine. - **Lauric acid** is a medium-chain fatty acid with antimicrobial properties and is commonly found in coconut oil; it is used in some dietary supplements and may have anti-inflammatory and lipid-modulating effects. - **Omeprazole** is a proton pump inhibitor that reduces stomach acid secretion by inhibiting the H+/K+ ATPase in gastric parietal cells; it is widely used to treat gastroesophageal reflux disease, peptic ulcers, and related conditions. - **N-acetyl cysteine (NAC)** is a mucolytic agent and antioxidant; it works primarily by replenishing intracellular glutathione and breaking disulfide bonds in mucus, resulting in reduced viscosity. NAC is also an approved antidote for acetaminophen toxicity and is used in several respiratory (e.g., COPD, cystic fibrosis), hepatic, and investigational indications[1][2][3][4][5][7][9][10]. This triple combination does not correspond to any standard or widely approved pharmaceutical product. Each component has distinct mechanisms and indications, and this combination might be considered for research or as an experimental therapy. No evidence was found for a branded formulation or specific developer of this three-drug product.